Development and validation of an ELISA for the quantification of pig major acute phase protein (Pig-MAP).

Vet Immunol Immunopathol

Departamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, 50009 Zaragoza, Spain.

Published: February 2009

Measurement of acute phase proteins (APPs) levels in blood is increasingly being used for monitoring health and welfare in farm animals. In this work a sandwich-type ELISA for the quantification of pig Major Acute phase Protein (Pig-MAP), one of the main APP in pigs, has been developed and validated. Two Pig-MAP specific monoclonal antibodies were developed in mouse. One of the monoclonal antibodies was fixed to microtiter plates and the other was coupled to horseradish peroxidase and used as detection antibody. To calibrate the assay dilutions of a standard pig serum of known Pig-MAP concentration were added to the plate in each assay. The assay showed good accuracy, kept linearity under dilution and recovery was proportional. The detection limit was 0.1 microg/mL. Precision was adequate with coefficients of variation lower than 8% for both inter and intra-assays. A good linear correlation between Pig-MAP concentration values obtained by ELISA and by radial immunodiffusion, used as reference method, was found (r = 0.978; beta = 1.02). Pig-MAP concentration was analysed in serum samples obtained from two pig herds of different health status (10 animals per age and herd, of 10, 12, 14, 18 weeks of age). Mean values obtained in the farm of low health status were higher than the obtained in the farm of high health status (p<0.001). In the farm of high health status, mean Pig-MAP concentration remained constant at the different ages analysed (mean values of 0.83+/-0.18 mg/mL) whereas in the farm of low health status differences between age groups were found. In this farm (low health status) mean values for the total of pigs analysed were of 1.68+/-0.74 mg/mL.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vetimm.2008.10.318DOI Listing

Publication Analysis

Top Keywords

acute phase
12
pig-map concentration
12
health status
12
elisa quantification
8
quantification pig
8
pig major
8
major acute
8
phase protein
8
protein pig-map
8
monoclonal antibodies
8

Similar Publications

Histological differences among thrombi in thrombotic diseases.

Curr Opin Hematol

January 2025

Department of Pathology, Section of Oncopathology and Morphological Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

Purpose Of Review: This review aims to summarize the histological differences among thrombi in acute myocardial infarction, ischemic stroke, venous thromboembolism, and amniotic fluid embolism, a newly identified thrombosis.

Recent Findings: Acute coronary thrombi have a small size, are enriched in platelets and fibrin, and show the presence of fibrin and von Willebrand factor, but not collagen, at plaque rupture sites. Symptomatic deep vein thrombi are large and exhibit various phases of time-dependent histological changes.

View Article and Find Full Text PDF

Importance: Nelonemdaz selectively antagonizes the 2B subunit of the N-methyl-d-aspartate glutamate receptor and scavenges free radical species.

Objective: To evaluate whether nelonemdaz enhances the clinical outcomes of patients with acute ischemic stroke undergoing emergent reperfusion therapy.

Design, Setting, And Participants: This multicenter double-blind placebo-controlled randomized phase 3 trial (December 25, 2021, to June 30, 2023, in South Korea) recruited patients with acute ischemic stroke who met the following criteria: National Institutes of Health Stroke Scale score greater than or equal to 8, Alberta Stroke Program Early Computed Tomography score greater than or equal to 4, and endovascular thrombectomy within 12 hours after stroke onset.

View Article and Find Full Text PDF

Background: Primary percutaneous coronary intervention (PPCI) and fibrinolytic or thrombolytic therapy are common treatments for ST-elevation myocardial infarction (STEMI). Primary percutaneous coronary intervention is more effective than thrombolytic therapy, but fibrinolytic therapy is still a preferable option for patients with limited access to healthcare. Alteplase is a tissue plasminogen activator (tPA) used to treat acute myocardial infarction, acute ischemic stroke, and pulmonary embolism.

View Article and Find Full Text PDF

Oedema index trajectories at heart failure nurse clinics over 6 months after acute heart failure predict patient outcomes: a retrospective cohort study.

Eur J Cardiovasc Nurs

January 2025

Heart Failure Research Center, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, 222 Mai Chin Road, Keelung 20401, Taiwan.

Aims: Fluid accumulation is associated with poor outcomes in patients with heart failure (HF). After acute HF, HF nurses provide home care suggestions based on oedema status assessed at outpatient clinics. However, the pattern of serial oedema changes and their associations with patient outcomes are unknown.

View Article and Find Full Text PDF

Recovery support services as part of the continuum of care for alcohol or drug use disorders.

Addiction

January 2025

Harvard Medical School and Center for Addiction Medicine, Recovery Research Institute, at Massachusetts General Hospital, Boston, MA, USA.

Background: The definition of 'recovery' has evolved beyond merely control of problem substance use to include other aspects of health and wellbeing (known as 'recovery capital') which are important to prevent relapse to problematic alcohol or other drug (AOD) use. Developing a Recovery Oriented System of Care (ROSC) requires consideration of interventions or services (Recovery Support Services, RSS) designed to build recovery capital which are often delivered alongside established treatment structures. Lived experience and its application to the process of engaging people, changing behaviour and relapse prevention is an essential part of these services.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!